We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-1.34%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.17B
AUM Growth
+$393M
Cap. Flow
+$459M
Cap. Flow %
39.32%
Top 10 Hldgs %
24.34%
Holding
4,355
New
842
Increased
1,505
Reduced
871
Closed
1,089

Sector Composition

Rank Sector Weight
1 Financials 6.75%
2 Industrials 5.87%
3 Consumer Discretionary 5.39%
4 Technology 4.75%
5 Healthcare 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEVA icon
2001
Teva Pharmaceuticals
TEVA
$42.1B
$28K ﹤0.01%
1,620
+1,428
+744% +$27.9K
TNK icon
2002
Teekay Tankers
TNK
$2.64B
$28K ﹤0.01%
2,976
+2,745
+1,188% +$27.3K
VCYT icon
2003
Veracyte
VCYT
$3.72B
$28K ﹤0.01%
4,942
-8,073
-62% -$50K
PRMW
2004
DELISTED
Primo Water Corporation
PRMW
$28K ﹤0.01%
1,900
-3,706
-66% -$58.8K
ITI
2005
DELISTED
Iteris, Inc.
ITI
$28K ﹤0.01%
5,482
+4,155
+313% +$25.8K
SPRT
2006
DELISTED
support.com, Inc.
SPRT
$28K ﹤0.01%
10,051
-4,727
-32% -$12.9K
TLND
2007
DELISTED
Talend S.A. American Depositary Shares
TLND
$28K ﹤0.01%
+574
New +$24.5K
JNP
2008
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$28K ﹤0.01%
2,796
-329
-11% -$2.76K
BHVN
2009
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$28K ﹤0.01%
+1,088
New +$32.5K
CGEN icon
2010
Compugen
CGEN
$221M
$27K ﹤0.01%
5,988
+4,746
+382% +$16K
CYD icon
2011
China Yuchai International
CYD
$1.73B
$27K ﹤0.01%
1,292
-412
-24% -$9.95K
DENN
2012
DELISTED
Denny's
DENN
$27K ﹤0.01%
1,734
+474
+38% +$7.13K
EC icon
2013
Ecopetrol
EC
$35.1B
$27K ﹤0.01%
+1,418
New +$25.3K
FPI
2014
Farmland Partners
FPI
$424M
$27K ﹤0.01%
+3,284
New +$26.7K
HNRG icon
2015
Hallador Energy
HNRG
$748M
$27K ﹤0.01%
3,898
+2,834
+266% +$18.8K
MGNI icon
2016
Magnite
MGNI
$3.47B
$27K ﹤0.01%
14,990
+13,530
+927% +$25.6K
MPB icon
2017
Mid Penn Bancorp
MPB
$945M
$27K ﹤0.01%
+860
New +$28.2K
PFGC icon
2018
Performance Food Group
PFGC
$17.9B
$27K ﹤0.01%
891
+716
+409% +$22.9K
RDN icon
2019
Radian Group
RDN
$4.87B
$27K ﹤0.01%
1,400
-1,829
-57% -$38.5K
RPD icon
2020
Rapid7
RPD
$776M
$27K ﹤0.01%
+1,038
New +$25.1K
HIND
2021
Vyome Holdings
HIND
$15.5M
0
THRM icon
2022
Gentherm
THRM
$1.27B
$27K ﹤0.01%
+790
New +$25.6K
VRTX icon
2023
Vertex Pharmaceuticals
VRTX
$133B
$27K ﹤0.01%
166
-371
-69% -$60.6K
TBNK
2024
DELISTED
Territorial Bancorp Inc.
TBNK
$27K ﹤0.01%
921
-236
-20% -$7.25K
AERI
2025
DELISTED
Aerie Pharmaceuticals
AERI
$27K ﹤0.01%
503
+433
+619% +$24.2K

Similar funds

Tower Research Capital (TRC)'s Q1 2018 Portfolio in Review

As of Q1 2018, Tower Research Capital (TRC) held 4,355 positions worth $1.17B, up 51% from $775M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Tower Research Capital (TRC) deployed $459M of net new capital in Q1 2018, opening 842 new positions and adding to 1,505 existing holdings. Its largest new stake was iShares MSCI EAFE ETF: 717,758 shares worth $50M.

By sector, the portfolio is most concentrated in Financials at 6.7% of assets, down from 11% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $21M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2018 buy was iShares MSCI EAFE ETF: 717,758 shares worth $50M.
  • Tower Research Capital (TRC) added most to iShares MSCI Emerging Markets ETF in Q1 2018, an estimated $69.7M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $21M.
  • Tower Research Capital (TRC) fully exited Berkshire Hathaway Class B in Q1 2018, selling an estimated $7.94M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 24% of its $1.17B portfolio in Q1 2018.
  • Tower Research Capital (TRC) opened 842 new positions and closed 1,089 in Q1 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 51% quarter-over-quarter to $1.17B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2018, filed 15 May 2018.